☆ 4.4 Letter

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

TRIALS (2021)

Get Full Text
Add to Collection

Journal

TRIALS
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13063-020-04964-1

Keywords

COVID-19; randomised controlled trial; protocol; acute respiratory distress syndrome; mesenchymal stromal cells

Categories

Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.